FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Triangle Compounding Histamine Recall

Histamine, 10 ng/mL Injectable, MDV, Rx only, Triangle Compounding Pharmacy, 3700 Regen…

Triangle Compounding · Cary, NC

Risk level
Class II
Reported by FDA
Oct 9, 2013
Recall ID
D-1069-2013
Check your lot numberHow we source this data

Summary

Triangle Compounding recalled Histamine starting Sep 6, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1069-2013 on Oct 9, 2013. Reason: Lack of Assurance of Sterility:The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility:The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.

Product description

Histamine, 10 ng/mL Injectable, MDV, Rx only, Triangle Compounding Pharmacy, 3700 Regency Parkway, Suite 140, Cary NC 27518.

Lot numbers, UPCs & expiration codes

Lot 74651-LG4973, Exp 12/4/13

Where it was sold

NC

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1069-2013
Classification
Class II
Status
Terminated
Recall initiated
Sep 6, 2013
FDA report date
Oct 9, 2013
Quantity
8 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Triangle Compounding

Original FDA data

Every field from FDA enforcement report D-1069-2013, exactly as published.

Show all FDA fields
City
Cary
State
NC
Status
Terminated
Country
United States
Event ID
66297
Address
3700 Regency Pkwy Ste 140
Code information
Lot 74651-LG4973, Exp 12/4/13
Postal code
27518-8696
Report date
Oct 9, 2013
Product type
Drugs
Recall number
D-1069-2013
Classification
Class II
Recalling firm
Triangle Compounding
Product quantity
8 vials
Termination date
Apr 23, 2025
Reason for recall
Lack of Assurance of Sterility:The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Histamine, 10 ng/mL Injectable, MDV, Rx only, Triangle Compounding Pharmacy, 3700 Regency Parkway, Suite 140, Cary NC 27518.
Distribution pattern
NC
Recall initiation date
Sep 6, 2013
Initial firm notification
Telephone
Center classification date
Sep 30, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1069-2013, published Oct 9, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls